[1]
2024. CTHRC1 is associated with BRAF(V600E) mutation and correlates with prognosis, immune cell infiltration, and drug resistance in colon cancer, thyroid cancer, and melanoma. Biomolecules and Biomedicine. 25, 1 (Dec. 2024), 42–61. DOI:https://doi.org/10.17305/bb.2024.10397.